Clinical Trials

1,407 enrolled

Breast Neoplasms

NCT05461430 2026-04-13

TraveraRTGx

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

72 enrolled

Anus Neoplasms, Appendiceal Neoplasms, Ascites, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Small Cell, Carcinoma, Pancreatic Ductal, Gastrointestinal Stromal Tumors

NCT07512063 2026-04-13

A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors

480 enrolled

Breast Neoplasms

NCT05399329 2026-04-09

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

693 enrolled

Breast Neoplasms

NCT05478590 2026-04-03

A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting

440 enrolled

Breast Neoplasms

NCT06962969 2026-04-02

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

1 enrolled

Breast Neoplasms

NCT07476170 2026-04-02

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

14,000 enrolled

Breast Neoplasms

NCT04943497 2026-04-01

PROSPERITY

2,424 enrolled

Breast Neoplasms

NCT05377684 2026-04-01

ROSE

450 enrolled

Breast Neoplasms

NCT06830720 2026-04-01

CAROLEEN

3,250 enrolled

Breast Neoplasms

NCT06905301 2026-04-01

IMPULSE

240 enrolled

Breast Neoplasms

NCT07498413 2026-04-01

ROTOR

218,677 enrolled

Breast Neoplasms, Disease Progression

NCT07505797 2026-04-01

AUDIBLE

800 enrolled

Breast Diseases, Breast Neoplasms, Cystic Fibrosis, Fibroadenoma, Mastodynia

NCT04654208 2026-03-31

SIRI

1,500 enrolled

Breast Neoplasms

NCT06856343 2026-03-25

REBECCA

126 enrolled

Breast Neoplasms

NCT04158258 2026-03-24

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

2,907 enrolled

Breast Neoplasms

NCT06827132 2026-03-23

CASCADE

600 enrolled

BreastThoracic

Breast Neoplasms, Lung Neoplasms

NCT07347600 2026-03-20

reaINAVO

500 enrolled

Breast Neoplasms

NCT06417801 2026-03-19

Pangeia-2

70 enrolled

Breast Neoplasms

NCT06428799 2026-03-18

EMBLEDDA-MMG

122 enrolled

Breast Neoplasms

NCT06833853 2026-03-18

CTC-EXPRESS

187 enrolled

Breast Neoplasms

NCT05662345 2026-03-17

ACT-MBC

65 enrolled

Breast Neoplasms

NCT05697146 2026-03-16

RosaLEE

1,019 enrolled

Breast Neoplasms

NCT06610539 2026-03-16

MAGProm

184 enrolled

Breast Neoplasms

NCT06930859 2026-03-16

ELEGANCE

2,766 enrolled

Breast Neoplasms

NCT05677308 2026-03-13

LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

61 enrolled

Breast Neoplasms

NCT05913440 2026-03-12

HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

1,669 enrolled

Breast Neoplasms

NCT07219277 2026-03-11

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

2,000 enrolled

Breast Neoplasms

NCT07459062 2026-03-09

SPCTR-I

100 enrolled

Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

900 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04498481 2026-02-27

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

1 enrolled

Breast Neoplasms

NCT05573893 2026-02-27

PROVIDENCE

800 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07070128 2026-02-24

STAR-BREAST

800 enrolled

Breast Neoplasms

NCT07427407 2026-02-24

Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

Not yet recruiting

100 enrolled

Breast Neoplasms

NCT05022342 2026-02-23

SPEAR

595 enrolled

Breast Neoplasms

NCT05974150 2026-02-23

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

BreastGynecologicOther hematologic neoplasmPlasma cellThoracic

25 enrolled

Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Ovarian Neoplasms, Leukemia, Myeloid, Acute

NCT07008963 2026-02-23

Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant

48 enrolled

Breast Neoplasms

NCT05939128 2026-02-12

ERA

625 enrolled

Breast Neoplasms

NCT05945732 2026-02-12

DESTINY Breast Respond HER2-low Europe

1,155 enrolled

Breast Neoplasms

NCT07342309 2026-02-10

Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

7,933 enrolled

Breast Neoplasms

NCT06797531 2026-02-04

NISLEESA

177 enrolled

Breast Neoplasms

NCT05054010 2026-02-02

Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants

84 enrolled

Breast Neoplasms

NCT06097156 2026-01-30

Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications

45 enrolled

Breast Neoplasms

NCT06311383 2026-01-27

RIBANNA

2,610 enrolled

Breast Neoplasms

NCT07363434 2026-01-23

RESONATE

335 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07186296 2026-01-21

EXoPERT EMERALD Clinical Study

BreastGastrointestinalGynecologicThoracic

1,400 enrolled

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT05366881 2026-01-20

CAMPERR

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

7,000 enrolled

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06401421 2026-01-20

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

1,800 enrolled

Breast Neoplasms

NCT06227728 2026-01-16

PTC-IMPACT